Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethel Cesarman

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Blood Advances|October 26, 2020
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypesHanna Scholze, Regan E Stephenson, Raymond Reynolds, et al.
Blood|March 12, 2020
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapyTanner Dalton, Ekaterina Doubrovina, Dmitry Pankov, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Artificial Intelligence-based Diagnosis of Kaposi Sarcoma using Photographs in Dark-skinned PatientsSarah J Coates, Feng Yang, Cody Hill, et al.
The Journal of Clinical Investigation|May 16, 2017
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignanciesUtthara Nayar, Jouliana Sadek, Jonathan Reichel, et al.
JCO Global Oncology|July 23, 2020
Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming BarriersLilie L Lin, David S Lakomy, Elizabeth Y Chiao, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
Blood|May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
The Lancet. Haematology|August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trialPaul G Rubinstein, Page C Moore, Milan Bimali, et al.
Blood|December 22, 2009
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Blood|September 19, 2014
FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphomaMarion J Vogel, Linka Xie, Hanfeng Guan, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Blood Advances|October 26, 2020
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypesHanna Scholze, Regan E Stephenson, Raymond Reynolds, et al.
Blood|March 12, 2020
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapyTanner Dalton, Ekaterina Doubrovina, Dmitry Pankov, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Artificial Intelligence-based Diagnosis of Kaposi Sarcoma using Photographs in Dark-skinned PatientsSarah J Coates, Feng Yang, Cody Hill, et al.
The Journal of Clinical Investigation|May 16, 2017
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignanciesUtthara Nayar, Jouliana Sadek, Jonathan Reichel, et al.
JCO Global Oncology|July 23, 2020
Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming BarriersLilie L Lin, David S Lakomy, Elizabeth Y Chiao, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
Blood|May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
The Lancet. Haematology|August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trialPaul G Rubinstein, Page C Moore, Milan Bimali, et al.
Blood|December 22, 2009
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Blood|September 19, 2014
FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphomaMarion J Vogel, Linka Xie, Hanfeng Guan, et al.
Pageof 15